By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has entered into an exclusive collaboration with Novartis to develop tools intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the international scale.

The Austin, Texas-based firm said that it would distribute the Armored RNA Quant BCR-ABL1 RNA International Scale calibrators and software reporting tools directly or through distributors worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.